USOR Texas Oncology — Abilene, Texas

USOR Texas Oncology is a clinical research site located in Abilene, Texas, United States 79606.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

USOR Texas Oncology has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: High Grade Epithelial Ovarian Cancer, High Grade Serous Ovarian Cancer, Primary Peritoneal Carcinoma.

Sponsors: Genmab.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Abilene

Browse all research sites in Texas · View every site in Abilene

• Retina Research Institute of Texas
• Hendrick Medical Center
• Texas Oncology West Texas
• Texas Oncology-Abilene
• Retina Res Institute of Texas
• Texas Cancer Center/Abilene
• Texas Cancer Center
• Hendrick Cancer Center
• Hendrick Health
• West Texas Retina Consultants P.A.
• Velocity Clinical Research Abilene
• Novartis Investigative Site

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for USOR Texas Oncology?

USOR Texas Oncology has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has USOR Texas Oncology conducted?

USOR Texas Oncology has 1 clinical trials on record, with 1 currently active. Their work covers High Grade Epithelial Ovarian Cancer, High Grade Serous Ovarian Cancer, Primary Peritoneal Carcinoma.

Is USOR Texas Oncology accredited by Crixeo Clinical Trials?

USOR Texas Oncology has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about USOR Texas Oncology?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.